F. Castellino
University of Turin
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by F. Castellino.
World Journal of Gastrointestinal Endoscopy | 2012
M. Ayoubi; G. Sansoè; Nicola Leone; F. Castellino
AIM To compare the rates of success and complications of two different methods of access into the common bile duct (CBD). METHODS Between October 2007 and November 2008, 173 consecutive patients (71 men, 102 women, mean age 68.6 years) requiring endoscopic retrograde cannulation of the papilla and endoscopic treatment were studied. In the first 88 patients CBD cannulation was performed through supra-papillary fistulotomy (group F); in the following 85 patients standard cannulation was performed through the Oddi sphincter (group S). Indications for the procedure were: choledocholithiasis, biliary obstruction, postoperative leak, sclerosing cholangitis, and Mirizzis syndrome. RESULTS Deep CBD cannulation was successful in 85/88 patients (96.5%) in group F vs 60/85 patients (70.6%) in group S (P < 0.0001). The remaining 25 group S patients in whom cannulation failed were shifted to fistulotomy. Fistulotomy was successful in 21/25 patients (84%). As for complications, hyperamilasemia occurred in 7 (7.9%) group F patients vs 7 (8.2%) group S patients (P = NS); mild pancreatitis in 1 (1.1%) group F patient vs 5 (5.8%) group S patients (P = NS); bleeding in 3 (3.4%) group F patients vs 3 (3.5%) group S patients (P = NS). CONCLUSION Needle-knife fistulotomy should represent either the first approach to therapeutic cannulation or rescue therapy after unsuccessful standard cannulation.
Digestive and Liver Disease | 2010
E. Tarabra; P. Pazienza; E. Borghesio; Giovanni C. Actis; G. Tappero; L. Framarin; M. Ayoubi; F. Castellino; Nicola Leone; G. Sansoè; Paolo De Paolis; Alessandro Comandone; Floriano Rosina
BACKGROUND The activity of epithelial lactase (LCT) associates with a polymorphism 13910 bp upstream the LCT-encoding gene (LCT-13910C>T). The relationship between LCT-13910C>T polymorphism and risk for colorectal cancer is unclear. AIMS We examined the relationship between the LCT-13910C>T polymorphism causing lactose intolerance and risk for colorectal cancer/polyps onset in the Italian population. PATIENTS AND METHODS 793 subjects (306 with colorectal cancer, 176 with polyps and 311 controls) were genotyped for the LCT-13910C>T variant by TaqMan real time-PCR. RESULTS Lactose malabsorption linked to the CC genotype did not associate with an increased risk for either colorectal cancer (OR=1.041; 95% CI=0.751-1.442; p=0.868) or polyps (OR=0.927; 95% CI=0.630-1.363; p=0.769). There was no association with colorectal cancer/polyps site. 60% of the subjects overall bore the CC genotype. CONCLUSION In the Italian population the LCT-13910C>T polymorphism is not associated to the risk for colorectal cancer or polyps.
Current Diabetes Reports | 2018
Antonio Sircana; L. Framarin; Nicola Leone; Mara Berrutti; F. Castellino; Renato Parente; Franco De Michieli; Elena Paschetta; Giovanni Musso
Purpose of ReviewIn the last decade many studies have suggested an association between the altered gut microbiota and multiple systemic diseases including diabetes. In this review, we will discuss potential pathophysiological mechanisms, the latest findings regarding the mechanisms linking gut dysbiosis and type 2 diabetes (T2D), and the results obtained with experimental modulation of microbiota.Recent FindingsIn T2D, gut dysbiosis contributes to onset and maintenance of insulin resistance. Different strategies that reduce dysbiosis can improve glycemic control.SummaryEvidence in animals and humans reveals differences between the gut microbial composition in healthy individuals and those with T2D. Changes in the intestinal ecosystem could cause inflammation, alter intestinal permeability, and modulate metabolism of bile acids, short-chain fatty acids and metabolites that act synergistically on metabolic regulation systems contributing to insulin resistance. Interventions that restore equilibrium in the gut appear to have beneficial effects and improve glycemic control. Future research should examine in detail and in larger studies other possible pathophysiological mechanisms to identify specific pathways modulated by microbiota modulation and identify new potential therapeutic targets.
Digestive and Liver Disease | 2014
M. Ayoubi; F. Castellino; G. Sansoè; M. Berrutti; Nicola Leone; Floriano Rosina
Background: Carcinoid tumors are rare but considered to be one of the commonest tumors in the appendix. Their incidence has been shown to vary in different studies. Aims, setting & design: This seminal study was carried out to determine the incidence and clinico-pathological profile of appendiceal carcinoids in a cohort of patients undergoing emergency appendicectomies for clinically suspected acute appendicitis in Emirate of Sharjah. Material and methods: The study included the retrospective data of 964 patients operated for clinically suspected appendicitis, the resected specimens of whom were received in the Pathology laboratory of Al-Qasmi hospital Sharjah from January 2010 to December 2010. Results: Out of the 964 patients 9 (0.93%) were found to have appendiceal carcinoids. The mean age was 28.7 years with a male to female ratio of 2 :1. Eight tumors were located near the tip of appendix with mean diameter of 3.3 mm. All tumors were found to be positive for chromogranin A, synaptophysin and neuron-specific enolase on immunohistochemistry (IHC). None of the patients had recurrence or any reportable complications in the short follow up period (12–26 months). Conclusions: Our study found higher incidence of appendiceal carcinoids in patients undergoing emergency appendectomy for acute appendicitis in Emirate of Sharjah compared to two previous studies from the same geographical region. Moreover, tumors were found more commonly in young males in contrary to previous studies and all the tumors were positive for common neuroendocrine markers.
Digestive and Liver Disease | 2009
M. Ayoubi; F. Castellino; Nicola Leone; L. Framarin; Floriano Rosina
Digestive and Liver Disease | 2014
M. Ayoubi; F. Castellino; G. Sansoè; Floriano Rosina
Digestive and Liver Disease | 2012
M. Ayoubi; G. Sansoè; F. Castellino
Digestive and Liver Disease | 2011
M. Ayoubi; G. Sansoè; Nicola Leone; L. Framarin; S. Badalamenti; F. Castellino
Digestive and Liver Disease | 2011
M. Ayoubi; G. Sansoè; F. Castellino
Digestive and Liver Disease | 2009
Giovanni C. Actis; P. Pazienza; A. Parziale; M. Cicilano; G. Tappero; E. Tarabra; S. Chiaramello; M. Ayoubi; L. Framarin; A. Biava; E. Borghesio; P. De Paolis; A. Comandone; F. Castellino; Floriano Rosina